The prevalence of canine atopic dermatitis, an allergic and chronic skin disease in dogs, is on the rise, and it is becoming a major concern for pet owners and veterinarians worldwide. Transparency Market Research (TMR) conducted a study projecting that the global Canine Atopic Dermatitis Market is expected to reach a valuation of US$ 16.1 Bn by the end of 2031. This article delves into the key findings of the study, shedding light on the causes, symptoms, and potential treatments for this condition.
Understanding Canine Atopic Dermatitis
Canine atopic dermatitis is a chronic skin disease in dogs that is primarily caused by exposure to various environmental allergens. These allergens can include substances such as grass, mold spores, house dust mites, and other common environmental elements. When dogs are exposed to these allergens, they can develop an allergic reaction, leading to a range of uncomfortable symptoms.
Symptoms of Canine Atopic Dermatitis
Dogs suffering from atopic dermatitis often display a range of distressing symptoms, including:
- Excessive scratching: Dogs may scratch themselves vigorously in an attempt to alleviate itching.
- Itching: Dogs may experience severe itching, which can lead to further discomfort.
- Skin inflammation: Inflamed skin is a common result of atopic dermatitis, often accompanied by redness.
- Rubbing and licking: Dogs may focus their rubbing and licking around areas like the face, paws, and underarms, where itching and discomfort are most pronounced.
It’s worth noting that genetics also play a role in the susceptibility of dogs to atopic dermatitis. A family history of skin allergies in dogs can increase their vulnerability to various allergens such as animal dander, airborne pollen, mold spores, and house dust mites.
Key Drivers and Restraints
The TMR study identifies several factors driving the global market for canine atopic dermatitis:
- Rise in Prevalence: The prevalence of canine atopic dermatitis is increasing, with studies indicating a range from 3% to 30% in clinical populations.
- Awareness and Therapeutic Advancements: Increased awareness of early signs and symptoms of allergic reactions in animals, along with advancements in therapeutic methods, are boosting market growth.
- Environmental Factors: The rise in pollution and allergen levels is contributing to the increased incidence of atopic dermatitis in dogs.
However, the market also faces restraints, particularly in the form of drug-induced severe hypersensitivity reactions. Some drugs can exacerbate allergic reactions, and improper management of the condition, such as incorrect dosage and drug combinations, can hinder market growth.
Treatment Options
The TMR study categorizes treatment options for canine atopic dermatitis into various segments:
- Immunotherapy: Immunotherapy is considered the gold standard for allergy therapy, as it can modify the immune system’s response to allergies. This is different from suppressing the immune system or merely alleviating clinical signs.
- Injectable Treatment: Injectable treatments are becoming increasingly popular due to the convenience of a once-a-month injection, as opposed to twice-daily oral medications.
Distribution Channels
The market also involves various distribution channels:
- Veterinary Hospitals: Veterinary hospitals dominate the market due to the availability of advanced therapies and expert consultation.
- Pet Clinics: Pet clinics also play a significant role in providing care and treatment for dogs with atopic dermatitis.
- Pharmacies & Drug Stores: These retail outlets offer medications for managing the condition.
Global Market Overview
North America currently leads the global canine atopic dermatitis market. This is due to the higher prevalence of the condition in the region, the presence of advanced veterinary care facilities, and the development of new therapies and drugs for animal diseases. In the United States, for example, pet owners spent more than US$ 7.4 Bn on pet care in 2017, while in Europe, the expenditure was around US$ 6.1 Bn for the same year.
Key Manufacturers
Several key manufacturers are actively contributing to the global canine atopic dermatitis market, including:
- Zoetis
- Virbac
- Novartis AG
- Boehringer Ingelheim International GmbH
- AB Science
- TORAY INDUSTRIES, INC.
- Elanco
- Bimeda, Inc.
- Vetoquinol S.A.
- Ceva